Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-205,363
Closed -$2.02M 184
2023
Q3
$2.02M Sell
205,363
-2,976
-1% -$31K 0.13% 84
2023
Q2
$2.19M Sell
208,339
-10,529
-5% -$101K 0.13% 85
2023
Q1
$2.11M Buy
218,868
+18,299
+9% +$203K 0.13% 84
2022
Q4
$2.23M Buy
200,569
+30,824
+18% +$322K 0.14% 74
2022
Q3
$1.45M Buy
169,745
+50,142
+42% +$494K 0.1% 88
2022
Q2
$1.25M Buy
119,603
+31,585
+36% +$346K 0.08% 89
2022
Q1
$958K Buy
88,018
+18,568
+27% +$245K 0.05% 98
2021
Q4
$940K Buy
+69,450
New +$927K 0.05% 99
2014
Q2
$438K Hold
8,500
0.04% 85
2014
Q1
$432K Hold
8,500
0.04% 83
2013
Q4
$369K Hold
8,500
0.04% 86
2013
Q3
$324K Hold
8,500
0.04% 85
2013
Q2
$264K Buy
+8,500
New +$254K 0.03% 83

Other funds holding VTRS

Arvest Trust's VTRS Position: Q4 2023 in Review

Arvest Trust sold out of Viatris (VTRS) in Q4 2023, closing a stake of 205,363 shares — an estimated $2.02M sold.

Arvest Trust first reported a position in VTRS in Q2 2013 and held it in 13 quarters. The position peaked at $2.23M in Q4 2022. 1,016 funds tracked by Wall St. Rank hold VTRS as of Q4 2023.

  • Arvest Trust reported no remaining Viatris position as of Q4 2023 after selling out during the quarter.
  • Arvest Trust sold 205,363 Viatris shares in Q4 2023, an estimated $2.02M.
  • Arvest Trust first reported a position in Viatris in Q2 2013 and held it in 13 quarters.
  • Arvest Trust's Viatris position peaked at $2.23M in Q4 2022.
  • 1,016 funds tracked by Wall St. Rank held Viatris as of Q4 2023.

Based on Arvest Trust's 13F filing for Q4 2023, filed 24 Jan 2024.